Pasithea Therapeutics (KTTA) Total Liabilities (2021 - 2024)
Historic Total Liabilities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $823975.0.
- Pasithea Therapeutics' Total Liabilities fell 6392.1% to $823975.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $823975.0, marking a year-over-year decrease of 6392.1%. This contributed to the annual value of $2.7 million for FY2023, which is 136.34% up from last year.
- According to the latest figures from Q3 2024, Pasithea Therapeutics' Total Liabilities is $823975.0, which was down 6392.1% from $1.5 million recorded in Q2 2024.
- Pasithea Therapeutics' 5-year Total Liabilities high stood at $4.6 million for Q3 2021, and its period low was $823975.0 during Q3 2024.
- For the 4-year period, Pasithea Therapeutics' Total Liabilities averaged around $2.3 million, with its median value being $2.5 million (2024).
- In the last 5 years, Pasithea Therapeutics' Total Liabilities skyrocketed by 16424.12% in 2023 and then crashed by 6392.1% in 2024.
- Over the past 4 years, Pasithea Therapeutics' Total Liabilities (Quarter) stood at $1.9 million in 2021, then skyrocketed by 41.14% to $2.7 million in 2022, then rose by 1.36% to $2.7 million in 2023, then tumbled by 69.69% to $823975.0 in 2024.
- Its Total Liabilities stands at $823975.0 for Q3 2024, versus $1.5 million for Q2 2024 and $2.5 million for Q1 2024.